257 related articles for article (PubMed ID: 33856300)
1. Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis.
Ruslan MA; Baharuddin KA; Noor NM; Yazid MB; Noh AYM; Rahman A
West J Emerg Med; 2021 Feb; 22(2):196-203. PubMed ID: 33856300
[TBL] [Abstract][Full Text] [Related]
2. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
[TBL] [Abstract][Full Text] [Related]
3. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
[TBL] [Abstract][Full Text] [Related]
4. THE EFFICACY AND SAFETY OF VASOPRESSORS FOR SEPTIC SHOCK PATIENTS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS.
Jia L; Wang P; Li C; Xie J
Shock; 2023 Dec; 60(6):746-752. PubMed ID: 37548686
[TBL] [Abstract][Full Text] [Related]
5. Vasopressors for hypotensive shock.
Havel C; Arrich J; Losert H; Gamper G; Müllner M; Herkner H
Cochrane Database Syst Rev; 2011 May; (5):CD003709. PubMed ID: 21563137
[TBL] [Abstract][Full Text] [Related]
6. Vasopressors for hypotensive shock.
Gamper G; Havel C; Arrich J; Losert H; Pace NL; Müllner M; Herkner H
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD003709. PubMed ID: 26878401
[TBL] [Abstract][Full Text] [Related]
7. A comparison of epinephrine and norepinephrine in critically ill patients.
Myburgh JA; Higgins A; Jovanovska A; Lipman J; Ramakrishnan N; Santamaria J;
Intensive Care Med; 2008 Dec; 34(12):2226-34. PubMed ID: 18654759
[TBL] [Abstract][Full Text] [Related]
8. Vasopressors for shock.
Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis.
Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H
Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
11. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.
McIntyre WF; Um KJ; Alhazzani W; Lengyel AP; Hajjar L; Gordon AC; Lamontagne F; Healey JS; Whitlock RP; Belley-Côté EP
JAMA; 2018 May; 319(18):1889-1900. PubMed ID: 29801010
[TBL] [Abstract][Full Text] [Related]
12. Effect of norepinephrine on the outcome of septic shock.
Martin C; Viviand X; Leone M; Thirion X
Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
[TBL] [Abstract][Full Text] [Related]
13. Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis.
Song JU; Lee J; Park HK; Suh GY; Jeon K
J Korean Med Sci; 2020 Jan; 35(1):e8. PubMed ID: 31898435
[TBL] [Abstract][Full Text] [Related]
14. Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis.
Li Y; Li H; Zhang D
Crit Care; 2020 Aug; 24(1):488. PubMed ID: 32762765
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
Menich BE; Miano TA; Patel GP; Hammond DA
Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
17. Practice Patterns in the Initiation of Secondary Vasopressors and Adjunctive Corticosteroids during Septic Shock in the United States.
Bosch NA; Teja B; Wunsch H; Walkey AJ
Ann Am Thorac Soc; 2021 Dec; 18(12):2049-2057. PubMed ID: 33975530
[No Abstract] [Full Text] [Related]
18. Impact of Norepinephrine Weight-Based Dosing Compared With Non-Weight-Based Dosing in Achieving Time to Goal Mean Arterial Pressure in Obese Patients With Septic Shock.
Vadiei N; Daley MJ; Murthy MS; Shuman CS
Ann Pharmacother; 2017 Mar; 51(3):194-202. PubMed ID: 27886982
[TBL] [Abstract][Full Text] [Related]
19. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell JA; Lee T; Singer J; De Backer D; Annane D
J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of norepinephrine versus dopamine for septic shock: a meta analysis].
Zhou FH; Song Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):449-54. PubMed ID: 24021037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
